Open AccessActivity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model
Author(s) -
Yun Cai,
Deqing Yang,
Jin Wang,
Rui Wang
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx399
Subject(s) - meropenem , colistin , rifampicin , ex vivo , pharmacology , in vivo , pseudomonas aeruginosa , microbiology and biotechnology , antibiotics , carbapenem , medicine , combination therapy , biology , bacteria , antibiotic resistance , genetics
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) infections represent a major therapeutic problem and combination therapy may be the chemotherapeutic option.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom